Last Price | 16.60 | Max Price | 93.05 |
Min Price | 16.60 | 1 Year return | 0.00 |
Avg. Target | 95.00 | Expected Return | 472.29 % |
Sector | Health Care | Subsector | Pharmaceuticals |
Sell | 0 | Rating |
![]() ![]() ![]() ![]() ![]() |
Hold | 0 | Concensus |
![]() |
Buy | 2 |
Contact info:Country: Germany
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 0 | 615,670 | 0.00 % |
2020 | 0 | 638,104 | 0.00 % |
2021 | 0 | 727,997 | 0.00 % |
2022 | 0 | 787,317 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
---|---|---|---|---|---|
March 17, 2025 | Jefferies & Co. | DocMorris | Buy | 39.00 | 57.44 % |
March 17, 2025 | Deutsche Bank | DocMorris | Hold | 25.00 | 33.60 % |
March 16, 2025 | Baader Bank | DocMorris | Buy | 44.00 | 62.27 % |
March 16, 2025 | M.M. Warburg & Co. | DocMorris | Hold | 33.00 | 49.70 % |
February 08, 2025 | UBS | DocMorris | Sell | 16.00 | -3.75 % |
August 25, 2024 | Stifel | DocMorris | Buy | 60.00 | 72.33 % |
April 14, 2024 | Hauck & Aufhauser | DocMorris | Buy | 130.00 | 87.23 % |
September 03, 2024 | Jefferies & Co. | DocMorris | Buy | 65.00 | 74.46 % |
August 25, 2024 | UBS | DocMorris | Sell | 27.00 | 38.52 % |
August 25, 2024 | Deutsche Bank | DocMorris | Hold | ||
May 19, 2024 | UBS | DocMorris | Sell | 31.90 | 47.96 % |
April 14, 2024 | Jefferies & Co. | DocMorris | Buy | 110.00 | 84.91 % |
March 17, 2024 | Jefferies & Co. | DocMorris | Buy | 90.00 | 81.56 % |
January 15, 2024 | Baader Bank | DocMorris | Buy | 60.00 | 67.53 % |
January 10, 2024 | Morgan Stanley | DocMorris | Hold | 69.00 | 71.77 % |
No Records Found
No Records Found
No Records Found
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
0
|
0
|
0
|
0
|
0
|
|
Costs |
0
|
0
|
0
|
0
|
0
|
|
Profit |
0
|
0
|
0
|
0
|
0
|
|
Margin of profit |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
ROI |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
0
|
0
|
0
|
0
|
0
|
|
Debt |
0
|
0
|
0
|
0
|
0
|
|
Total assets |
0
|
0
|
0
|
0
|
0
|
|
Solvency |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
|
Cashflow |
0
|
0
|
0
|
0
|
0
|
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
0.0
|
0.0
|
0.0
|
0.0
|
16.60
|
Eps |
0.0
|
0.0
|
0.0
|
0.0
|
|
Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
0.0
|
0.0
|
0.0
|
0.0
|
|
Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow per stock |
0.0
|
0.0
|
0.0
|
0.0
|
|
Stocks |
0
|
0
|
0
|
0
|
|
Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
|
Date
|
Price
|
---|---|
15 Mar 2025
|
16.60
|
12 Mar 2025
|
20.96
|
01 Mar 2025
|
20.46
|
25 Feb 2025
|
20.68
|
23 Feb 2025
|
21.02
|
18 Feb 2025
|
19.08
|
13 Feb 2025
|
18.43
|
12 Feb 2025
|
18.83
|
07 Feb 2025
|
18.80
|
05 Feb 2025
|
20.10
|
02 Feb 2025
|
19.86
|
21 Jan 2025
|
21.52
|
17 Jan 2025
|
19.77
|
09 Jan 2025
|
19.48
|
17 Dec 2024
|
24.68
|
10 Dec 2024
|
25.96
|
06 Dec 2024
|
26.56
|
03 Dec 2024
|
29.50
|
29 Nov 2024
|
29.80
|
13 Nov 2024
|
37.56
|
08 Nov 2024
|
33.98
|
05 Nov 2024
|
33.18
|
31 Oct 2024
|
35.26
|
29 Oct 2024
|
33.82
|
23 Oct 2024
|
30.28
|
19 Oct 2024
|
31.62
|
16 Oct 2024
|
31.64
|
14 Oct 2024
|
30.80
|
05 Oct 2024
|
31.42
|
02 Oct 2024
|
36.70
|